JF
COYA icon

Jump Financial’s Coya Therapeutics COYA Stock Holding History

Jump Financial’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Sell
17,300
-3,700
-18% -$17.1K ﹤0.01% 1903
2026
Q1 		$82.7K Sell
21,000
-13,200
-39% -$61.7K ﹤0.01% 1764
2025
Q4 		$198K Buy
+34,200
New +$208K ﹤0.01% 1755

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Jump Financial's COYA Position: Q2 2026 in Review

Jump Financial reduced its Coya Therapeutics (COYA) stake by 18% in Q2 2026, selling an estimated $17.1K and leaving 17,300 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

Jump Financial first reported a position in COYA in Q4 2025 and has held it in 3 quarters since. The position peaked at $198K in Q4 2025. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Jump Financial held 17,300 shares of Coya Therapeutics worth $101K as of Q2 2026.
  • Jump Financial sold 3,700 Coya Therapeutics shares in Q2 2026, an estimated $17.1K.
  • Coya Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1903 holding.
  • Jump Financial first reported a position in Coya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Jump Financial's Coya Therapeutics position peaked at $198K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.